Palliative chemoradiation boosts survival, QoL in poor-prognosis NSCLC
C hemoradiation is superior to chemotherapy alone with respect to both survival and quality of life in patients with inoperable non-small-cell lung cancer, a phase III trial has found.
No comments:
Post a Comment